[Asia Economy Reporter Hyunseok Yoo] The U.S. Centers for Disease Control and Prevention (CDC) announced on the 19th (local time) that individuals who experience severe allergic reactions after receiving the novel coronavirus infection (COVID-19) vaccine should not receive the second dose.


The CDC stated, "We have received reports of severe allergic reactions in some vaccine recipients," and added, "Those who experienced such side effects after the first dose should not receive the second dose."


The CDC defines 'severe allergy' as a physical reaction requiring the administration of epinephrine, an allergy medication, or hospitalization.


The CDC recommended that individuals who have previously experienced severe allergic reactions to other vaccines consult their primary care physician before receiving the COVID-19 vaccine. However, it added that those who have had severe allergies unrelated to vaccination can still receive the COVID-19 vaccine.


Regarding allergic side effects, Dr. Tom Clark of the CDC reported that since starting Pfizer vaccine administration on the 14th, 272,001 people have been vaccinated, among whom 6 have shown side effects.



Prior to the U.S., the United Kingdom, which began administering the Pfizer vaccine on the 8th, also reported two cases of severe allergic reactions. The UK health authorities have prohibited the second dose for individuals who experience such reactions. Pfizer's vaccine requires the second dose to be administered three weeks after the first dose.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing